Prevalence and Incidence of Dementia in People with Diabetes Mellitus.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2020
Historique:
pubmed: 21 4 2020
medline: 11 5 2021
entrez: 21 4 2020
Statut: ppublish

Résumé

Few studies have shown that an increased risk of dementia is associated with diabetes mellitus. To estimate the prevalence and incidence of dementia in people with diabetes in primary care in the UK. We conducted a descriptive study using the UK The Health Improvement Network (THIN) database. People diagnosed with diabetes from 2000 to 2016 were included in the study. Prevalence and incidence rates of dementia were calculated annually, stratified by age and gender. The prevalence of dementia was 0.424% [95% CI (0.420%-0.427%)] in 2000 and 2.508% [95% CI (2.501%-2.515%)] in 2016. The highest prevalence was in those aged 85+ from 2.9% [95% CI (2.890%-2.974%)] in 2000 to 11.3% [95% CI (11.285%-11.384%)] in 2016. The incidence of dementia increased 3.7 times, from 0.181 cases per 100 persons [95% CI (0.179-0.183)] in 2000 to 0.683 cases per 100 persons [95% CI (0.679-0.686)] in 2016, respectively. Women had a higher prevalence and incidence of dementia than men 3.138% [95% CI (3.127%-3.150%)] versus 2.014% [95% CI (2.006%-2.022%)] and 0.820 [95% CI (0.814-0.826)] versus 0.576 cases per 100 persons [95% CI (0.571-0.580)] in 2016, respectively. There was a trend of increasing prevalence and incidence of dementia in people with diabetes over the period of 2000 to 2016. This study adds to the evidence on dementia prevalence and incidence, particularly in the diabetic population.

Sections du résumé

BACKGROUND
Few studies have shown that an increased risk of dementia is associated with diabetes mellitus.
OBJECTIVE
To estimate the prevalence and incidence of dementia in people with diabetes in primary care in the UK.
METHODS
We conducted a descriptive study using the UK The Health Improvement Network (THIN) database. People diagnosed with diabetes from 2000 to 2016 were included in the study. Prevalence and incidence rates of dementia were calculated annually, stratified by age and gender.
RESULTS
The prevalence of dementia was 0.424% [95% CI (0.420%-0.427%)] in 2000 and 2.508% [95% CI (2.501%-2.515%)] in 2016. The highest prevalence was in those aged 85+ from 2.9% [95% CI (2.890%-2.974%)] in 2000 to 11.3% [95% CI (11.285%-11.384%)] in 2016. The incidence of dementia increased 3.7 times, from 0.181 cases per 100 persons [95% CI (0.179-0.183)] in 2000 to 0.683 cases per 100 persons [95% CI (0.679-0.686)] in 2016, respectively. Women had a higher prevalence and incidence of dementia than men 3.138% [95% CI (3.127%-3.150%)] versus 2.014% [95% CI (2.006%-2.022%)] and 0.820 [95% CI (0.814-0.826)] versus 0.576 cases per 100 persons [95% CI (0.571-0.580)] in 2016, respectively.
CONCLUSION
There was a trend of increasing prevalence and incidence of dementia in people with diabetes over the period of 2000 to 2016. This study adds to the evidence on dementia prevalence and incidence, particularly in the diabetic population.

Identifiants

pubmed: 32310163
pii: JAD191115
doi: 10.3233/JAD-191115
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

607-615

Subventions

Organisme : Medical Research Council
ID : G106/1249
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Auteurs

Alaa A Alsharif (AA)

Department of Pharmacy Practice, Faculty of Pharmacy, Princess Norah Bint Abdulrahman University, Riyadh, Kingdom of Saudi Arabia.
Research Department of Practice and Policy, University College London School of Pharmacy, London, United Kingdom.

Li Wei (L)

Research Department of Practice and Policy, University College London School of Pharmacy, London, United Kingdom.

Tiantian Ma (T)

Research Department of Practice and Policy, University College London School of Pharmacy, London, United Kingdom.

Kenneth K C Man (KKC)

Research Department of Practice and Policy, University College London School of Pharmacy, London, United Kingdom.
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Wallis C Y Lau (WCY)

Research Department of Practice and Policy, University College London School of Pharmacy, London, United Kingdom.
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

Ruth Brauer (R)

Research Department of Practice and Policy, University College London School of Pharmacy, London, United Kingdom.

Mansour Almetwazi (M)

Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

Rob Howard (R)

Division of Psychiatry, University College London, London, United Kingdom.

Ian C K Wong (ICK)

Research Department of Practice and Policy, University College London School of Pharmacy, London, United Kingdom.
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH